Company profile
Jilin Weiyuan was established in 2010. At present, the business department has more than 200 employees and a total of more than 10,000 offline terminal business customers.
Weiyuan Pharmaceutical Factory was established in 2022 and has an integrated supply chain of product research and development, production, marketing, promotion and distribution. The product system includes: tablets, powders, broths, pastes and other varieties. At present, more than 2,000 varieties have been developed.
In order to accelerate the pace of enterprise group discovery, Lijun Group joined hands with Weibang Pharmaceutical to develop new e-commerce marketing cooperation models such as online, public domain and private domain on the basis of the original terminal and offline business. The factory undertakes OEM, ODM, etc., and implements market protection contract business. Introduce multiple high-end production lines, vigourously develop large health product lines, blue cap products, special meals, medicinal and food origin series, etc. The products have passed PICC quality assurance, GMP certification, and are about to pass FDA certification, 9001 system certification, etc.
Weiyuan Group strictly requires the production of big health products with the standards of pharmaceutical enterprises, adheres to the values of conscientious products to guide customers, and the guiding concept of "pragmatic, professional and innovative", and conveys the noble mission of improving human health life. It is committed to becoming the guide of China's big health industry and for the overall health cause of human beings. Development, hard work, dedication, innovation and vigourous progress!
| Main Sales Markets:North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa |
Registration number:440300207716939 |
| Main Competitive Advantages:Brandname |
Main Product Categories:Industrial Services |
| All Sales(USD):choose not to disclose |
Main Customer Name: |